Literature DB >> 6187500

Ultracentrifugation in swinging-bucket and fixed-angle rotors evaluated for isolation and determination of high-density lipoprotein subfractions HDL2 and HDL3.

P N Demacker, D F van Sommeren-Zondag, A F Stalenhoef, P M Stuyt, A van't Laar.   

Abstract

We evaluated the density-gradient ultracentrifugation method in a swinging-bucket rotor (Anal Biochem 111, 149-157, 1981) in a slightly modified version for isolation and determination of high-density lipoprotein (HDL) subfractions. We prestained the serum with Coomassie Brilliant Blue R, which did not change the hydrated densities of the lipoproteins, and after only 2.2 X 10(8) gav . min obtained an equilibrium distribution of the lipoproteins along the gradient. The density distribution of the HDL of 120 sera obtained from apparently healthy persons and from patients with different types of hyperlipoproteinemia was bimodal. The HDL2 could be isolated in the density range 1.072-1.098 kg/L and the HDL3 at 1.100-1.176 kg/L, the latter fraction being more heterogeneous. At a solvent density of 1.100 we obtained similar results for HDL2-and HDL3-cholesterol by ultracentrifugation in two different fixed-angle rotors with tube angles of 15 degrees or 35 degrees. Independent of the rotor and the ultracentrifugation technique, subfractionation at d = 1.100 resulted in more distinct stained entities than ultracentrifugation at d = 1.125. In the swinging-bucket rotor procedure, interference by sinking pre-beta-lipoproteins was minimized because, having hydrated densities between 1.058 and 1.075, they could be removed without aspirating the HDL2. The method is both accurate and precise. For HDL2- and HDL3-cholesterol determined in a thawed frozen serum pool, CVs were 8.8 and 6.3%, respectively (n = 18).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187500

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Changes in plasma lipids and lipoprotein cholesterol during a high altitude mountaineering expedition (4800 m).

Authors:  J Férézou; J P Richalet; T Coste; C Rathat
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

2.  Plasma catecholamines and lipoproteins in chronic psychological stress.

Authors:  L O'Donnell; N O'Meara; D Owens; A Johnson; P Collins; G Tomkin
Journal:  J R Soc Med       Date:  1987-06       Impact factor: 5.344

3.  Alterations in cellular cholesterol metabolism following administration of 6-hydroxydopamine to rabbits.

Authors:  N M O'Meara; R A Devery; D Owens; P B Collins; A H Johnson; G H Tomkin
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

4.  Low-density lipoprotein turnover in inbred strains of rabbits hypo- or hyperresponsive to dietary cholesterol.

Authors:  G W Meijer; A F Stalenhoef; P N Demacker; M J Mol; L F Van Zutphen; A C Beynen
Journal:  Lipids       Date:  1992-06       Impact factor: 1.880

5.  Effects of dicentrine on haemodynamic, plasma lipid, lipoprotein level and vascular reactivity in hyperlipidaemic rats.

Authors:  S M Yu; Y F Kang; C C Chen; C M Teng
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

6.  Clearance from plasma of lymph chylomicrons and chylomicron remnants labelled with 125I-tyramine-cellobiose.

Authors:  H L Ly; B C Mortimer; E Baker; T G Redgrave
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

7.  Effects of hypothyroidism on the metabolism of lipid emulsion models of triacylglycerol-rich lipoproteins in rats.

Authors:  T G Redgrave; C L Elsegood; J C Mamo; M J Callow
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

8.  High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study.

Authors:  Elke Arts; Jaap Fransen; Heidi Lemmers; Anton Stalenhoef; Leo Joosten; Piet van Riel; Calin D Popa
Journal:  Arthritis Res Ther       Date:  2012-05-14       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.